Citation Impact
Citing Papers
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Anemia and Blood Transfusion in Critically Ill Patients
2002 Standout
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
Utilizing List Exchange and Nondirected Donation through ‘Chain’ Paired Kidney Donations
2006 StandoutNobel
Intravenous Immunoglobulin Induction Treatment in Flow Cytometry Cross-Match—Positive Kidney Transplant Recipients
2005
Selective Depletion of Low-Density CD8 + , CD16 + Lymphocytes During HIV Infection
1988 StandoutNobel
Clinical Results From Transplanting Incompatible Live Kidney Donor/Recipient Pairs Using Kidney Paired Donation
2005
Incompatible Live-Donor Kidney Transplantation in the United States
2011
A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody
2006
A Nonsimultaneous, Extended, Altruistic-Donor Chain
2009 StandoutNobel
Comparison of Combination Plasmapheresis/IVIg/ Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
2009
The Acceptable Mismatch Program as a Fast Tool for Highly Sensitized Patients Awaiting a Cadaveric Kidney Transplantation: Short Waiting Time and Excellent Graft Outcome
2004
Determinants of Poor Graft Outcome in Patients with Antibody-Mediated Acute Rejection
2007
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
Drug-Induced Acute Pancreatitis
1989
Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study
2007
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Mechanism of Accommodation in a Sensitized Human Leukocyte Antigen Transgenic Murine Cardiac Transplant Model
2012
Nonsimultaneous Chains and Dominos in Kidney- Paired Donation—Revisited
2011 StandoutNobel
Desensitization in HLA-Incompatible Kidney Recipients and Survival
2011
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange
2010
Toward Performing Transplantation in Highly Sensitized Patients
2004
Hepatitis C infection in two urban hemodialysis units
1990 StandoutNobel
Chronic kidney disease
2011 Standout
Plasma exchange conditioning for ABO‐incompatible renal transplantation
2004
Extending options for highly sensitized patients to receive a suitable kidney graft
2005
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
2004
Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
2008
Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
2009
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
Drug-Induced Acute Pancreatitis: An Evidence-Based Review
2007
Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific Antibodies
2008
Nodular regenerative hyperplasia of the liver and the Budd-Chiari syndrome
1991
Graft-versus-host disease
2009 Standout
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
The gastrointestinal tract in uremia
1993
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Acute Pancreatitis
1994 Standout
TWELVE MONTHS OF LAMIVUDINE TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS12
2000
Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease
2004
Disappearance of Hepatitis C Virus RNA in Plasma during Interferon Alpha-2B Treatment in Hemophilia Patients
1992 StandoutNobel
Clinicopathologic Course of Hepatitis B Infection in Surface Antigen Carriers Following Living-Related Renal Transplantation
1994
Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies
2002
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Prevention and treatment of alloantibody-mediated kidney transplant rejection
2011
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies
2009
Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation
2010
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors
2003
Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
2010
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
TRANSPLANT RENAL ARTERY STENOSIS IN 77 PATIENTS-DOES IT HAVE AN IMMUNOLOGICAL CAUSE?1
1996
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
2004
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients
2001
Infection in Organ-Transplant Recipients
1998 Standout
Mechanisms of transfusion‐induced immunosuppression
1990
An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*
1999 Standout
Humoral Theory of Transplantation
2003
Clinical Relevance of Preformed HLA Donor-Specific Antibodies in Kidney Transplantation
2008
Epstein–Barr Virus Infection
2000 Standout
Renal Transplantation Across HLA and ABO Antibody Barriers: Integrating Paired Donation into Desensitization Protocols
2010
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Desensitization in kidney transplantation: review and future perspectives
2014
What Have We Learned from Market Design?
2008 StandoutNobel
Desensitization for solid organ and hematopoietic stem cell transplantation
2014
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins
1986 StandoutNobel
Lymphadenopathy-Associated-Virus Infection and Acquired Immunodeficiency Syndrome
1986 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
Terminology of nodular hepatocellular lesions
1995 Standout
What Have We Learned from Market Design?
2008 StandoutNobel
Kidney paired donation
2011 StandoutNobel
What Have We Learned from Market Design?
2009 StandoutNobel
Risk of End-Stage Renal Disease Following Live Kidney Donation
2014 Standout
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors
1984
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
Efficient Kidney Exchange: Coincidence of Wants in Markets with Compatibility-Based Preferences
2007 StandoutNobel
Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome
1998
Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS.
1984
Efficient Kidney Exchange: Coincidence of Wants in a Markets with Compatibility-Based Preferences
2009 StandoutNobel
Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation
2006
Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients
1985
Works of A Duboust being referenced
Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
2000
Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)
2002
Vascular complications in the adult kidney transplant recipient
1992
Antidonor Antibodies and Transplantation: How to Deal with Them Before and After Transplantation
2005
Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies
2004
Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies
2004
Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.
1981
Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy.
1996
Peliosis hepatis in recipients of renal transplants.
1978
SUPPRESSION OF LYMPHOCYTE REACTIVITY BY BLOOD TRANSFUSIONS IN UREMIC PATIENTS
1983
Asymptomatic hyperamylasemia after cyclosporine therapy in patients with renal transplants.
1988
IS RENAL TRANSPLANTATION INVOLVED IN POST-TRANSPLANTATION LIVER DISEASE? A PROSPECTIVE STUDY
1980